MANILA, Philippines — CoronaVac, the COVID-19 vaccine from China’s Sinovac Biotech, can be used for individuals with “controlled” comorbidities, the Department of Health (DOH) said Monday.
In a Viber message to reporters, Health Undersecretary Maria Rosario Vergeire said that “based on experts of HTAC (Health Technology Assessment Council)and NITAG’s (National Immunization Technical Advisory Group) recommendations, also based on scientific studies, CoronaVac can be given to individuals with controlled comorbidities.”
The Food and Drug Administration (FDA) earlier recommended the use of CoronaVac to “clinically healthy” individuals aged 18 to 69, as studies showed th…
Keep on reading: CoronaVac can be used for people with ‘controlled’ comorbidity — DOH